Table 1

Demographic, anthropometric, and clinical characteristics of patients based on their ethnicity

Caucasian patients (n = 134)African American patients (n = 67)P value
Age (years)54 ± 1054 ± 90.72
Sex (male) (%)71700.85
BMI (kg/m2)33.9 ± 5.134.5 ± 5.20.43
Total body fat (%)36 ± 733 ± 80.004
Diagnosis of NAFLD (%)52250.003
T2DM (%)70730.66
Duration of T2DM (years)6.3 ± 5.75.3 ± 5.20.41
Fasting plasma glucose (mg/dL)139 ± 48127 ± 390.09
FPI (μIU/mL)12 ± 1012 ± 80.86
HbA1c (in T2DM) (%)7.1 ± 1.37.0 ± 1.00.81
Use of metformin (%)57520.57
Use of sulfonylureas (%)27240.66
Use of insulin (%)12200.20
Cholesterol (mg/dL)176 ± 46169 ± 370.34
Triglycerides (mg/dL)144 (97–210)97 (71–140)<0.001
HDL-C (mg/dL)39 ± 1046 ± 16<0.001
LDL-C (mg/dL)101 ± 38102 ± 310.94
Use of statins (%)68600.31
ALT (IU/L)43 ± 3337 ± 340.21
AST (IU/L)31 ± 1831 ± 260.98
  • Data are presented as mean ± SD or median (interquartile range) for the numeric variables and as percentage for the categorical variables. ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDL-C, LDL cholesterol.